Global Cluster Headache Syndrome Market: Overview
Cluster headache is a neurological disorder. It is a condition characterized by recurrence of severe headache usually around the eye on one side of the head. Cluster headache, in most cases, is accompanied by excessive tears, nasal decongestion, and swelling of the eye. Individuals suffering from cluster headache syndrome might often have to endure agonizing attacks of unilateral headaches.
The condition shows symptoms that are quite similar to migraine such as nausea and sensitivity to sound and light. The causes that trigger cluster headache are not completely known; however, possible rare causes could include dysfunction of the hypothalamus and smoking. In some patients, cluster headache syndrome could be hereditary. The intense pain felt during cluster headache may be caused by the dilation of blood vessels, which creates pressure on the trigeminal nerve.
A physical examination of the pupils can help doctors diagnose the signs of cluster headache. Globally, there have been several reports of misleading diagnosis of cluster headache syndrome. A cluster headache patient could suffer attacks multiple times a day, with each attack lasting not more than three hours. A patient is likely to endure these attacks daily for many weeks or months. These may diminish for a period; however, the relief could be temporary as cluster headache can recur after a year or even a few months in some cases.
Cluster headache syndrome is more prevalent in men than in women. The two types of cluster headaches are episodic and chronic. Of these, incidence of episodic cluster headaches is more common than the latter. About 10% patients suffering from cluster headaches are estimated to suffer from chronic syndrome.
The report provides a comprehensive overview of the global cluster headache syndrome market. It studies the various factors influencing the market’s trajectory and includes exhaustive information obtained from trusted industrial sources. Data thus sourced is presented in a logical chapter-wise format interspersed with infographics, statistics, and relevant tables.
Global Cluster Headache Syndrome Market: Key Opportunities and Threats
Increasing global geriatric population, rising incidence of cluster headache syndrome, and introduction of latest technologies in the health care industry are the key factors boosting the growth of the global cluster headache syndrome market. Rising willingness among people to spend more on health care treatments and awareness about the importance of early diagnosis of cluster headache is anticipated to boost market growth. However, inadequate knowledge among health care providers and unfavorable health care policies that adversely affect overall health care expenditure are hampering the growth of the global cluster headache syndrome market.
Global Cluster Headache Syndrome Market: Region-wise Outlook
Regionally, North America dominates the global cluster headache syndrome market, followed by Europe. Increasing incidence of the syndrome and adoption of advanced technologies to diagnose the syndrome drive the cluster headache syndrome market in North America.
Asia Pacific offers lucrative opportunities for market players due to increasing geriatric population and rising prevalence of cluster headache syndrome.
Global Cluster Headache Syndrome Market: Vendor Landscape
In order to study the competition prevailing in the market, the report profiles companies such as GlaxoSmithKline plc, ElectroCore Medical LLC, Autonomic Technologies, Inc., and AstraZeneca plc. The recent strategies adopted by these companies to gain a competitive advantage in the market are examined in the report in detail. The report also presents an executive-level blueprint of the strengths and weaknesses of the companies profiled. The threats and opportunities that these companies could face in the near future are also studied in detail.
Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Cluster Headache Syndrome Market during 2016- 2024
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453